Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Kanghai Phospholipid Biotechnology is a specialized life sciences company focused on the research, development, and manufacturing of high-purity medicinal phospholipids. The company provides a comprehensive portfolio of natural and synthetic phospholipids, including egg yolk lecithin, soybean lecithin, and various PEGylated lipids used in advanced drug delivery systems. These products are critical components for the formulation of liposomes, fat emulsions, and lipid nanoparticles (LNPs) for mRNA vaccines and oncology therapeutics. Nanjing Kanghai operates under strict GMP standards and serves as a key supplier and CDMO partner for pharmaceutical companies globally. Their expertise in lipid chemistry enables the development of complex drug delivery solutions for injectable and oral applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Kanghai Phospholipid Biotechnology.